Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.00, read 2026-10-24
Ethical does not pass the values gate
Price27.81 USD
Fair value34.61
Ethical score70.0/100
Our investment reviews on this name
2026-10-13Read Accumulation26.67+4.3% to today ✓Markdown gives way to Accumulation after a 10% slide in 7 weeks
2026-08-22Read Markdown29.67-6.3% to today ✓Markup gives way to Markdown after an 8% slide in 7 weeks
2026-07-02Read Markup32.28-13.8% to today First review on file: Markup with results news in the headlines
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Brookfield Business Corporation holds its Accumulation at $27.81. The statistical read favours the sellers, held for 58 days.
As held on the ledger · 2026-10-23
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 58 days
Price at the screen
$27.81
Valuation
N/A trailing · 8.68 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.39
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
58.83%
Below 33%
Interest-bearing debt is 58.8% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
6.96%
Below 33%
Cash held in interest-bearing accounts and securities is 7.0% of assets, under the one-third limit.
Pass
Receivables
13.33%
Below 49%
Money owed to the company is 13.3% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Brookfield Business's business is in a permissible area, but its interest-bearing debt is about 59% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BBUC's ethical verdict changes
Today BBUC does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 29.5% margin of safety to the base estimate.
Third-party analyst targets: 8 covering, consensus Buy. The average target sits +49% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Conglomerate bets that deliver little growth or profit
Picture a private equity shop rolling up businesses in energy, construction and services across the globe. The pieces keep moving but sales are falling 5 percent and the bottom line sits at zero. At 12 times forward earnings the multiple looks reasonable until you notice return on equity stuck at just 2 percent.
We pass because the opportunity rating is none. A slim 4 percent margin of safety at the current price does not compensate for negative revenue momentum and the unknown durability of any competitive edge. Analyst price targets sit higher yet the numbers on the ground show a business struggling to compound capital.
Risk sits in the cyclical nature of its industrial holdings and the chance that peak earnings already sit behind us. Low multiples in this sector often signal value traps rather than bargains. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Bermuda and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
BBUC trades on the NYSE (the company is based in Bermuda). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-27Accumulation$26.72-0.2%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (6 analysts) rates it buy, with a mean price target of $42.
2026-10-20Accumulation$26.77+0.4%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (6 analysts) rates it buy, with a mean price target of $42.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (6 analysts) rates it buy, with a mean price target of $42.
2026-10-02Markdown$25.41-14.4%Entry 6
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 14.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (6 analysts) rates it buy, with a mean price target of $42.
2026-08-22Markdown · changed$29.67-5.1%Entry 5
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (6 analysts) rates it buy, with a mean price target of $42.
2026-07-22Markup$31.25-3.2%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (6 analysts) rates it buy, with a mean price target of $42.
2026-07-18Markup$32.28+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (6 analysts) rates it buy, with a mean price target of $42.
2026-07-03Markup$32.28+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Markup$32.28Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
